SC II Acquisition Files for $150M IPO

Dow Jones

Oct 17

By Stephen Nakrosis

SC II Acquisition, a blank-check company affiliated with Nukkleus, filed for a $150 million initial public offering.

The company said its sponsor, SC Capital II Sponsor, is an indirect subsidiary of Nukkleus which is a financial technology company whose shares trade on the Nasdaq under the symbol NUKK.

SC II said Menachem Shalom, its chief executive and a director, has been CEO of Nukkleus since September 2024. Shalom is also CEO and a director of special purpose acquisition company Kochav Defense Acquisition, which completed its IPO in May.

Asaf Yarkoni, SC II's chief financial officer, has been CFO of Kamari Pharma since 2021, and is also CFO of Kochav Defense Acquisition.

SC II said it hasn't selected a business combination target, and may pursue an acquisition opportunity in any business, industry, sector or geographical location.

The company applied to list its units on The Nasdaq Global Market under the symbol SCIIU.

Write to Stephen Nakrosis at stephen.nakrosis@wsj.com

(END) Dow Jones Newswires

October 16, 2025 18:14 ET (22:14 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2576713837"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2576713837\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2576713837?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-17 06:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2576713837","market":"fut","top_or_hot":-1,"title":"SC II Acquisition Files for $150M IPO","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Stephen Nakrosis \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  SC II Acquisition, a blank-check company affiliated with <a href=\"https://laohu8.com/S/NUKK\">Nukkleus</a>, filed for a $150 million initial public offering. \n</p>\n<p>\n  The company said its sponsor, SC Capital II Sponsor, is an indirect subsidiary of Nukkleus which is a financial technology company whose shares trade on the Nasdaq under the symbol NUKK. \n</p>\n<p>\n  SC II said Menachem Shalom, its chief executive and a director, has been CEO of Nukkleus since September 2024. Shalom is also CEO and a director of special purpose acquisition company Kochav Defense Acquisition, which completed its IPO in May. \n</p>\n<p>\n  Asaf Yarkoni, SC II's chief financial officer, has been CFO of Kamari Pharma since 2021, and is also CFO of Kochav Defense Acquisition. \n</p>\n<p>\n  SC II said it hasn't selected a business combination target, and may pursue an acquisition opportunity in any business, industry, sector or geographical location. \n</p>\n<p>\n  The company applied to list its units on The Nasdaq Global Market under the symbol SCIIU. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Stephen Nakrosis at stephen.nakrosis@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  October 16, 2025 18:14 ET (22:14 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SC II Acquisition Files for $150M IPO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSC II Acquisition Files for $150M IPO\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-10-17 06:14</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Stephen Nakrosis \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  SC II Acquisition, a blank-check company affiliated with <a href=\"https://laohu8.com/S/NUKK\">Nukkleus</a>, filed for a $150 million initial public offering. \n</p>\n<p>\n  The company said its sponsor, SC Capital II Sponsor, is an indirect subsidiary of Nukkleus which is a financial technology company whose shares trade on the Nasdaq under the symbol NUKK. \n</p>\n<p>\n  SC II said Menachem Shalom, its chief executive and a director, has been CEO of Nukkleus since September 2024. Shalom is also CEO and a director of special purpose acquisition company Kochav Defense Acquisition, which completed its IPO in May. \n</p>\n<p>\n  Asaf Yarkoni, SC II's chief financial officer, has been CFO of Kamari Pharma since 2021, and is also CFO of Kochav Defense Acquisition. \n</p>\n<p>\n  SC II said it hasn't selected a business combination target, and may pursue an acquisition opportunity in any business, industry, sector or geographical location. \n</p>\n<p>\n  The company applied to list its units on The Nasdaq Global Market under the symbol SCIIU. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Stephen Nakrosis at stephen.nakrosis@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  October 16, 2025 18:14 ET (22:14 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NUKK","symbol_name":"Nukkleus","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2576713837","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2576713837","pubTimestamp":1760652840,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"SC II Acquisition, a blank-check company affiliated with Nukkleus, filed for a $150 million initial public offering.The company said its sponsor, SC Capital II Sponsor, is an indirect subsidiary of Nukkleus which is a financial technology company whose shares trade on the Nasdaq under the symbol NUKK.SC II said Menachem Shalom, its chief executive and a director, has been CEO of Nukkleus since September 2024. Shalom is also CEO and a director of special purpose acquisition company Kochav Defense Acquisition, which completed its IPO in May.Asaf Yarkoni, SC II's chief financial officer, has been CFO of Kamari Pharma since 2021, and is also CFO of Kochav Defense Acquisition.SC II said it hasn't selected a business combination target, and may pursue an acquisition opportunity in any business, industry, sector or geographical location.The company applied to list its units on The Nasdaq Global Market under the symbol SCIIU.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"NUKK":"Nukkleus","BK4023":"应用软件"},"translate_title":"SC II Acquisition申请1.5亿美元IPO","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NQmain":0.65,"NUKK":0.9},"content_text":"By Stephen Nakrosis \n\n\n \n\n\n  SC II Acquisition, a blank-check company affiliated with Nukkleus, filed for a $150 million initial public offering. \n\n\n  The company said its sponsor, SC Capital II Sponsor, is an indirect subsidiary of Nukkleus which is a financial technology company whose shares trade on the Nasdaq under the symbol NUKK. \n\n\n  SC II said Menachem Shalom, its chief executive and a director, has been CEO of Nukkleus since September 2024. Shalom is also CEO and a director of special purpose acquisition company Kochav Defense Acquisition, which completed its IPO in May. \n\n\n  Asaf Yarkoni, SC II's chief financial officer, has been CFO of Kamari Pharma since 2021, and is also CFO of Kochav Defense Acquisition. \n\n\n  SC II said it hasn't selected a business combination target, and may pursue an acquisition opportunity in any business, industry, sector or geographical location. \n\n\n  The company applied to list its units on The Nasdaq Global Market under the symbol SCIIU. \n\n\n \n\n\n  Write to Stephen Nakrosis at stephen.nakrosis@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 16, 2025 18:14 ET (22:14 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}